SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-13-132443
Filing Date
2013-03-28
Accepted
2013-03-28 16:37:01
Documents
6

Document Format Files

Seq Description Document Type Size
1 424(B)(3) d511470d424b3.htm 424B3 1073280
2 GRAPHIC g511470006.jpg GRAPHIC 61484
3 GRAPHIC g511470007.jpg GRAPHIC 43705
4 GRAPHIC g511470009.jpg GRAPHIC 43217
5 GRAPHIC g511470016.jpg GRAPHIC 23475
6 GRAPHIC g511470018.jpg GRAPHIC 50359
  Complete submission text file 0001193125-13-132443.txt   1381372
Mailing Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108
Business Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108 (801) 582-5400
Q Therapeutics, Inc. (Filer) CIK: 0001366541 (see all company filings)

IRS No.: 203708500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-182447 | Film No.: 13724480
SIC: 2834 Pharmaceutical Preparations